Table 5.
Parameters | Study Groups | ANOVA Test p-Value * |
||||
---|---|---|---|---|---|---|
Control Group (N = 6) |
Mg Group (N = 6) |
SiNPs Group (N = 6) |
SiNPs + Mg Group (N = 6) |
|||
Liver | GSH (mean ± SD) | 2.72 ± 0.12 | 2.90 ± 0.07 bc | 1.38 ± 0.19 a | 1.97 ± 0.09 ab | F = 188.405 p < 0.001 ** |
MDA (mean ± SD) | 5.89 ± 0.37 | 4.92 ± 0.54 bc | 14.80 ± 1.11 a | 10.85 ± 1.07 ab | F = 182.136 p < 0.001 ** |
|
Kidney | GSH (mean ± SD) | 1.58 ± 0.15 | 1.69 ± 0.11 bc | 0.81 ± 0.11 a | 1.18 ± 0.04 ab | F = 81.313 p <0.001 ** |
MDA (mean ± SD) | 4.76 ± 0.26 | 4.02 ± 0.14 bc | 11.13 ± 0.98 a | 7.59 ± 0.85 ab | F = 141.260 p < 0.001 ** |
|
Adrenal | GSH (mean ± SD) | 1.47 ± 0.10 | 1.55 ± 0.05 bc | 0.70 ± 0.09 a | 8 ± 0.46 a | F = 127.623 p < 0.001 ** |
MDA (mean ± SD) | 3.92 ± 0.30 | 3.53 ± 0.25 bc | 1.09 ± 0.09 ab | 6.22 ± 0.16 ab | F = 269.944 p < 0.001 ** |
SD: standard deviation. SiNPs: silica nanoparticles. Mg: magnesium, GSH: glutathione. MDA: malondialdehyde. N: number. *: significant (p ˂ 0.05). **: highly significant (p ≤ 0.001). a: significant in relation to the control group. b: significant in relation to SiNPs group. c: significant in relation to SiNPs + Mg group.